CANCELED: Impact of the Affordable Care Act on Innovation, Access, and Affordability for Drugs and Biologics, Feb 28
The third lecture in the Implementing Health Care Reform in California Lecture Series will be presented by Kent Lieginger, PharmD, senior vice president, managed care […]